2-(3-(4-(3-(trifluoromethyl)-phenyl)-piperazin-1-yl)-propyl)-isoindoline-1,3-dione | 102392-02-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 2-(3-(4-(3-(trifluoromethyl)-phenyl)-piperazin-1-yl)-propyl)-isoindoline-1,3-dione
• 英文别名: 2-[3-[4-[3-(Trifluoromethyl)phenyl]piperazin-1-yl]propyl]isoindole-1,3-dione
• CAS: 102392-02-9
• 化学式: C₂₂H₂₂F₃N₃O₂
• 分子量: 417.431
• InChiKey: GSPDPTRQJAVCIP-UHFFFAOYSA-N

物化性质

• 沸点：
  533.9±50.0 °C(Predicted)
• 密度：
  1.308±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  30
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  43.9
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  2-(3-(4-(3-(trifluoromethyl)-phenyl)-piperazin-1-yl)-propyl)-isoindoline-1,3-dione 在 肼 作用下， 以 乙醇 为溶剂， 反应 2.0h， 以29%的产率得到1-(3-氨基-1-丙基)-4-[3-(三氟甲基)苯基]哌嗪
  参考文献：
  名称：

  UNC119-货物相互作用的小分子抑制。

  摘要：

  N-末端肉豆蔻酰化促进膜的结合和蛋白质（特别是Src家族激酶）的活性，但是其潜在机制才刚刚被人们理解。伴侣UNC119A / B调节N-肉豆蔻酰化蛋白的细胞分布和信号传导。UNC119-货物相互作用的选择性小分子调节剂将是无价的工具，但尚未有报道。我们在此报告了第一个UNC119-货物相互作用抑制剂squarunkin A的开发。SquarunkinA用IC 50选择性抑制代表Src激酶N端的肉豆蔻酰化肽与UNC119A的结合值为10 nm。它与细胞裂解物中的UNC119蛋白结合，并干扰Src激酶的激活。我们的研究结果表明，对UNC119-货物相互作用的小分子抑制可能为调节Src激酶的活性提供新的机会，而Src激酶的活性与直接抑制酶激酶的活性无关。

  DOI：

  10.1002/anie.201701905
• 作为产物：
  描述：

  N-(3-溴丙基)苯二胺 、 1-(3-三氟甲基苯基)哌嗪 以 正丁醇 为溶剂， 反应 20.0h， 生成 2-(3-(4-(3-(trifluoromethyl)-phenyl)-piperazin-1-yl)-propyl)-isoindoline-1,3-dione
  参考文献：
  名称：

  3取代和3-取代的N-[（4-芳基哌嗪-1-基）烷基]吡咯烷-2,5-二酮衍生物的亲脂性，抗惊厥活性和初步安全性的合成和测定

  摘要：

  描述了一系列新的1,3-取代的吡咯烷-2,5-二酮衍生物作为潜在的抗惊厥药。腹膜内给药后，通过在小鼠中使用癫痫发作的急性模型（MES和scPTZ测试）对这些化合物进行了初步的药理筛选。定量药理研究表明，最有前途的化合物是N -[{4-（3-三氟甲基苯基）哌嗪-1-基}丙基] -3-苯甲基吡咯烷-2-2.5-二酮一盐酸盐（11），ED 50值为75.9。 mg kg -1（MES测试）和N -[{4-（3,4-二氯苯基）哌嗪-1-基}乙基] -3-甲基吡咯烷-2-3,5-二酮一盐酸盐（18），ED 50 = 88.2 mg公斤-1（MES测试）和ED 50 = 65.7 kg mg -1（scPTZ测试）。与众所周知的抗癫痫药相比，这些化合物显示出更有益的保护指数。评估了化合物11和18的合理作用机制[分子11阻断了钠通道（部位2），而分子18阻断了钠（部位2）和L型钙通道），并评估了它们在

  DOI：

  10.1002/cmdc.201700539

文献信息

• Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1<i>H</i>-imidazo[2,1-<i>f</i>]purine-2,4(3<i>H</i>,8<i>H</i>)-dione as potential antidepressant agents
  作者：Agnieszka Zagórska、Adam Bucki、Marcin Kołaczkowski、Agata Siwek、Monika Głuch-Lutwin、Gabriela Starowicz、Grzegorz Kazek、Anna Partyka、Anna Wesołowska、Karolina Słoczyńska、Elżbieta Pękala、Maciej Pawłowski

  DOI：10.1080/14756366.2016.1198902

  日期：2016.11.3

  2-fluoro and 3-trifluoromethylphenylpiperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione (4-21) were synthesized and evaluated for their serotonin (5-HT1A/5-HT7) receptor affinity and phosphodiesterase (PDE4B and PDE10A) inhibitor activity. The study enabled the identification of potent 5-HT1A, 5-HT7 and mixed 5-HT1A/5-HT7 receptor ligands with weak inhibitory potencies for PDE4B and PDE10A

  合成了一系列的1H-咪唑并[2,1-f]嘌呤-2,4（3H，8H）-二酮（4-21）的2-氟和3-三氟甲基苯基哌嗪基烷基衍生物，并对其5-羟色胺（5-HT1A）进行了评估/ 5-HT7）受体亲和力和磷酸二酯酶（PDE4B和PDE10A）抑制剂的活性。该研究能够鉴定出对PDE4B和PDE10A具有弱抑制能力的有效5-HT1A，5-HT7和混合的5-HT1A / 5-HT7受体配体。已经使用胶束电动色谱（MEKC）系统和人肝微粒体（HLM）模型确定了亲脂性和代谢稳定性，从而完成了测试。在体内初步药理研究中，选择化合物8-（5-（4-（2-氟苯基）哌嗪-1-基）戊基）-1,3,7-三甲基-1H-咪唑并[2,1-f]嘌呤-2,4（3H，8H）-二酮（9）在小鼠的强迫游泳试验（FST）中表现为潜在的抗抑郁药。此外，由9引起的抗焦虑作用（2.5 mg / kg）要大于参考抗焦虑药地西epa。分子建模表明，1H-咪唑并[2
• Synthesis and Determination of Lipophilicity, Anticonvulsant Activity, and Preliminary Safety of 3-Substituted and 3-Unsubstituted<i>N</i>-[(4-Arylpiperazin-1-yl)alkyl]pyrrolidine-2,5-dione Derivatives
  作者：Sabina Rybka、Jolanta Obniska、Paweł Żmudzki、Paulina Koczurkiewicz、Katarzyna Wójcik-Pszczoła、Elżbieta Pękala、Adrian Bryła、Anna Rapacz

  DOI：10.1002/cmdc.201700539

  日期：2017.11.22

  l)piperazin‐1‐yl}propyl]‐3‐benzhydrylpyrrolidine‐2,5‐dione monohydrochloride (11) with a ED50 value of 75.9 mg kg−1 (MES test) and N‐[4‐(3,4‐dichlorophenyl)piperazin‐1‐yl}ethyl]‐3‐methylpyrrolidine‐2,5‐dione monohydrochloride (18) with ED50=88.2 mg kg−1 (MES test) and ED50=65.7 kg mg−1 (scPTZ test). These compounds displayed a more beneficial protective index than well‐known antiepileptic drugs. A

  描述了一系列新的1,3-取代的吡咯烷-2,5-二酮衍生物作为潜在的抗惊厥药。腹膜内给药后，通过在小鼠中使用癫痫发作的急性模型（MES和scPTZ测试）对这些化合物进行了初步的药理筛选。定量药理研究表明，最有前途的化合物是N -[4-（3-三氟甲基苯基）哌嗪-1-基}丙基] -3-苯甲基吡咯烷-2-2.5-二酮一盐酸盐（11），ED 50值为75.9。 mg kg -1（MES测试）和N -[4-（3,4-二氯苯基）哌嗪-1-基}乙基] -3-甲基吡咯烷-2-3,5-二酮一盐酸盐（18），ED 50 = 88.2 mg公斤-1（MES测试）和ED 50 = 65.7 kg mg -1（scPTZ测试）。与众所周知的抗癫痫药相比，这些化合物显示出更有益的保护指数。评估了化合物11和18的合理作用机制[分子11阻断了钠通道（部位2），而分子18阻断了钠（部位2）和L型钙通道），并评估了它们在
• Synthesis and biological evaluation of novel T-type Ca2+ channel blockers
  作者：Hee Kyung Jung、Munikumar Reddy Doddareddy、Joo Hwan Cha、Hyewhon Rhim、Yong Seo Cho、Hun Yeong Koh、Bong Young Jung、Ae Nim Pae

  DOI：10.1016/j.bmc.2004.06.011

  日期：2004.8.1

  A small molecule library of piperazinylalkylisoxazole derivatives containing about 600 compounds was designed, synthesized and evaluated for blocking effects on T-type Ca2+ channel. Several ligands were identified to possess high inhibitory activity against the T-type Ca2+ channel. The compound 21 with trifluoromethyl substituents at C-3-position of phenyl group (W) and C-2-position of phenyl group (R-2) showed the highest inhibitory activity with IC50 value of 1.02 muM, which is comparable to that of mibefradil. (C) 2004 Elsevier Ltd. All rights reserved.
• Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT2A receptor antagonists
  作者：Euna Yoo、Juhee Yoon、Ae Nim Pae、Hyewhon Rhim、Woo-Kyu Park、Jae Yang Kong、Hea-Young Park Choo

  DOI：10.1016/j.bmc.2009.12.067

  日期：2010.2

  A novel series of 5-HT2A ligands that contain a (phenylpiperazinyl-propyl)arylsulfonamides skeleton was synthesized. Thirty-seven N-(cycloalkylmethyl)-4-methoxy-N-(3-(4-arylpiperazin-1-yl)propyl)arylsulfonamide and N-(4-(4-arylpiperazin-1-yl)butan-2-yl)-arylsulfonamide compounds were obtained. The binding of these compounds to the 5-HT2A, 5-HT2C, and 5-HT7 receptors was evaluated. Most of the compounds showed IC50 values of less than 100 nM and exhibited high selectivity for the 5-HT2A receptor. Among the synthesized compounds, 16a and 16d showed good affinity at 5-HT2A (IC50 = 0.7 nM and 0.5 nM) and good selectivity over 5-HT2C (50-100 times) and 5-HT7 (1500-3000 times). (C) 2010 Elsevier Ltd. All rights reserved.
• Further optimization of novel pyrrole 3-carboxamides for targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant
  作者：Suk Youn Kang、Eun-Jung Park、Woo-Kyu Park、Hyun Jung Kim、Gildon Choi、Myung Eun Jung、Hee Jeong Seo、Min Ju Kim、Ae Nim Pae、Jeongmin Kim、Jinhwa Lee

  DOI：10.1016/j.bmc.2010.06.037

  日期：2010.8

  In the continuing search for novel compounds targeting serotonin 5-HT2A, 5-HT2C, and serotonin transporter, new arylpiperazine-containing pyrrole 3-carboxamide derivatives were synthesized and evaluated. Based on the lead reported previously, structural modifications regarding N-(3-(4-(2,3-dichlorophenyl)piperazin-1-yl)propyl)-1,2-dimethyl-5-phenyl-1H-pyrrole-3-carboxamide 5, were accomplished for improvements in not only binding affinity against serotonin receptors and transporter, but also in hERG channel inhibition. Along the line, both the forced swimming tests and spontaneous locomotor activity tests were performed to distinguish between antidepressant activity and false positive results. As potential antidepressant agents, both 2,4-dimethyl-5-phenyl-1H-pyrrole-3-carboxamide and 5-tert-butyl-2-methyl-1H-pyrrole-3-carboxamide derivatives exhibited favorable in vitro and in vivo activities, warranting further investigation around these scaffolds. (C) 2010 Elsevier Ltd. All rights reserved.